FDA — authorised 27 December 1995
- Application: NDA020541
- Marketing authorisation holder: ANI PHARMS
- Status: supplemented
FDA authorised Arimidex on 27 December 1995
Yes. FDA authorised it on 27 December 1995; FDA has authorised it.
ANI PHARMS holds the US marketing authorisation.